HealthLynked Statistics
Total Valuation
HealthLynked has a market cap or net worth of 14.98 million. The enterprise value is 21.10 million.
| Market Cap | 14.98M |
| Enterprise Value | 21.10M |
Important Dates
The next estimated earnings date is Thursday, May 14, 2026.
| Earnings Date | May 14, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
HealthLynked has 4.28 million shares outstanding. The number of shares has increased by 0.72% in one year.
| Current Share Class | 4.28M |
| Shares Outstanding | 4.28M |
| Shares Change (YoY) | +0.72% |
| Shares Change (QoQ) | +1.39% |
| Owned by Insiders (%) | 22.17% |
| Owned by Institutions (%) | 0.00% |
| Float | 3.33M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 7.26 |
| PB Ratio | -2.60 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -6.43 |
| EV / Sales | 10.22 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.22
| Current Ratio | 0.22 |
| Quick Ratio | 0.01 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -2.02 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -67.30% |
| Return on Invested Capital (ROIC) | -226.34% |
| Return on Capital Employed (ROCE) | 39.79% |
| Weighted Average Cost of Capital (WACC) | 15.75% |
| Revenue Per Employee | 258,162 |
| Profits Per Employee | -410,032 |
| Employee Count | 10 |
| Asset Turnover | 1.05 |
| Inventory Turnover | 34.10 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +16.67% in the last 52 weeks. The beta is 2.26, so HealthLynked's price volatility has been higher than the market average.
| Beta (5Y) | 2.26 |
| 52-Week Price Change | +16.67% |
| 50-Day Moving Average | 3.84 |
| 200-Day Moving Average | 2.56 |
| Relative Strength Index (RSI) | 50.14 |
| Average Volume (20 Days) | 1,234 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.03 |
Income Statement
In the last 12 months, HealthLynked had revenue of 2.07 million and -3.28 million in losses. Loss per share was -1.16.
| Revenue | 2.07M |
| Gross Profit | 997,181 |
| Operating Income | -2.11M |
| Pretax Income | -3.28M |
| Net Income | -3.28M |
| EBITDA | -2.01M |
| EBIT | -2.11M |
| Loss Per Share | -1.16 |
Balance Sheet
The company has 37,136 in cash and 6.15 million in debt, with a net cash position of -6.11 million or -1.43 per share.
| Cash & Cash Equivalents | 37,136 |
| Total Debt | 6.15M |
| Net Cash | -6.11M |
| Net Cash Per Share | -1.43 |
| Equity (Book Value) | -5.76M |
| Book Value Per Share | -2.00 |
| Working Capital | -5.46M |
Cash Flow
| Operating Cash Flow | -1.71M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 101,871 |
| Net Borrowing | 1.52M |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 48.28%, with operating and profit margins of -102.32% and -158.83%.
| Gross Margin | 48.28% |
| Operating Margin | -102.32% |
| Pretax Margin | -158.83% |
| Profit Margin | -158.83% |
| EBITDA Margin | -97.39% |
| EBIT Margin | -102.32% |
| FCF Margin | n/a |
Dividends & Yields
HealthLynked does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.72% |
| Shareholder Yield | -0.72% |
| Earnings Yield | -21.89% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on September 4, 2025. It was a reverse split with a ratio of 0.01.
| Last Split Date | Sep 4, 2025 |
| Split Type | Reverse |
| Split Ratio | 0.01 |
Scores
HealthLynked has an Altman Z-Score of -47.65 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -47.65 |
| Piotroski F-Score | 4 |